ADENOSINE A2 RECEPTORS AND PSYCHOSTIMULANT INTERACTIONS

腺苷 A2 受体和精神兴奋剂的相互作用

基本信息

  • 批准号:
    2770084
  • 负责人:
  • 金额:
    $ 29.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-08-01 至 2000-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Applicant's Abstract) Long-term administration of psychostimulant drugs produces enduring changes in behavior. It is likely that the long-term changes in brain function associated with prolonged drug exposure are important to addictive behavior. The molecular mechanisms underlying the persistent alteration in brain function associated with prolonged psychostimulant exposure are poorly understood. The behavioral effects of the psychostimulant amphetamine are dependent on activation of dopamine receptors within the striatum and limbic forebrain. Repeated administration of psychostimulants to rodents produces alterations in nuclear proteins which may underlie long-lasting changes in behavior. The A2a subtype of adenosine receptor is expressed in and regulates responsiveness of D2-expressing striatal and limbic forebrain neurons, and modulates the behavioral and nuclear responses of acute amphetamine. The A1 adenosine receptor also modulates AMPH-induced behavior, but the anatomical basis of this A1 effect is not understood. We hypothesize that striatal and limbic forebrain A2a and A1 adenosine receptors are sites where the acute effects of AMPH and enduring changes in brain function following chronic AMPH can be regulated. The expression of striatal and limbic forebrain A2a and A1 receptors will be characterized and the roles that these adenosinergic receptors play in modulating the behavioral and nuclear effects of acute and chronic AMPH administration will be investigated. These experiments will begin to identify nuclear mechanisms underlying this form of drug-induced neural plasticity which are vulnerable to modulation by forebrain adenosinergic receptors.
描述:(申请人摘要)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL A SCHWARZSCHILD其他文献

MICHAEL A SCHWARZSCHILD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL A SCHWARZSCHILD', 18)}}的其他基金

Planning for Prevention of Parkinson's Disease: a trial design forum
帕金森病预防规划:试验设计论坛
  • 批准号:
    10827547
  • 财政年份:
    2023
  • 资助金额:
    $ 29.85万
  • 项目类别:
2019 Parkinson Study Group Symposium and Training
2019年帕金森研究组研讨会及培训
  • 批准号:
    9763271
  • 财政年份:
    2019
  • 资助金额:
    $ 29.85万
  • 项目类别:
Urate-LRRK2 interactions in Parkinson's disease
尿酸盐-LRRK2在帕金森病中的相互作用
  • 批准号:
    10427325
  • 财政年份:
    2019
  • 资助金额:
    $ 29.85万
  • 项目类别:
Urate-LRRK2 interactions in Parkinson's disease
尿酸盐-LRRK2在帕金森病中的相互作用
  • 批准号:
    9978147
  • 财政年份:
    2019
  • 资助金额:
    $ 29.85万
  • 项目类别:
Urate-LRRK2 interactions in Parkinson's disease
尿酸盐-LRRK2在帕金森病中的相互作用
  • 批准号:
    10640903
  • 财政年份:
    2019
  • 资助金额:
    $ 29.85万
  • 项目类别:
Urate-LRRK2 interactions in Parkinson's disease
尿酸盐-LRRK2在帕金森病中的相互作用
  • 批准号:
    10210454
  • 财政年份:
    2019
  • 资助金额:
    $ 29.85万
  • 项目类别:
2019 Parkinson Study Group Symposium and Training
2019年帕金森研究组研讨会及培训
  • 批准号:
    9890023
  • 财政年份:
    2019
  • 资助金额:
    $ 29.85万
  • 项目类别:
2017 Parkinson Study Group Symposium and Training
2017年帕金森研究组研讨会及培训
  • 批准号:
    9398499
  • 财政年份:
    2017
  • 资助金额:
    $ 29.85万
  • 项目类别:
Phase 3 trial of inosine for Parkinson's disease CCC
肌苷治疗帕金森病 CCC 的 3 期试验
  • 批准号:
    9292399
  • 财政年份:
    2015
  • 资助金额:
    $ 29.85万
  • 项目类别:
Phase 3 trial of inosine for Parkinson's disease CCC
肌苷治疗帕金森病 CCC 的 3 期试验
  • 批准号:
    9258571
  • 财政年份:
    2015
  • 资助金额:
    $ 29.85万
  • 项目类别:

相似海外基金

Relationship between neurotoxicity and the chemical structures of amphetamines
安非他明的神经毒性与化学结构的关系
  • 批准号:
    25860103
  • 财政年份:
    2013
  • 资助金额:
    $ 29.85万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Search for protein expression in amphetamines treated mouse heart : Challenge to the diagnosis for the sudden death of amphetamines abusers
寻找安非他明治疗小鼠心脏中的蛋白质表达:对安非他明滥用者猝死诊断的挑战
  • 批准号:
    22659138
  • 财政年份:
    2010
  • 资助金额:
    $ 29.85万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8312648
  • 财政年份:
    2010
  • 资助金额:
    $ 29.85万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8531900
  • 财政年份:
    2010
  • 资助金额:
    $ 29.85万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8715749
  • 财政年份:
    2010
  • 资助金额:
    $ 29.85万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8144930
  • 财政年份:
    2010
  • 资助金额:
    $ 29.85万
  • 项目类别:
Translational Genetics and Dopamine Signaling in Sensitivity to Amphetamines
安非他明敏感性中的转化遗传学和多巴胺信号传导
  • 批准号:
    7675601
  • 财政年份:
    2009
  • 资助金额:
    $ 29.85万
  • 项目类别:
Simultaneous determination of ephedrines, amphetamines, cocaine, cocaine metabolites, and opiates and interaction in the rat
大鼠体内麻黄碱、安非他明、可卡因、可卡因代谢物和阿片类药物的同时测定及其相互作用
  • 批准号:
    17590585
  • 财政年份:
    2005
  • 资助金额:
    $ 29.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study for practical use of two chiral analyses of amphetamines by gas chromatography-mass spectrometry
气相色谱-质谱法对苯丙胺两种手性分析的实用化研究
  • 批准号:
    17590588
  • 财政年份:
    2005
  • 资助金额:
    $ 29.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical Pharmacology of 3,4-Methylenedioxy Amphetamines
3,4-亚甲二氧基安非他明的临床药理学
  • 批准号:
    6870119
  • 财政年份:
    2004
  • 资助金额:
    $ 29.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了